跳至主要内容
临床试验/NL-OMON52373
NL-OMON52373尚未招募不适用

Immunome project consortium for autoinflammatory disorders - ImmunAID

INSERM - Clinical Research Department (PRC)0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
0 至 99(—)

入选标准

  • Common criteria:
  • Patients covered by health insurance
  • Signature of the informed consent
  • For guSAID Patients
  • Patients with active disease (presence of a flare) according to the specific
  • criteria of each disease
  • SAID patients with an as yet unidentified genetic cause:
  • o Still Disease,
  • o Recurrent Pericarditis,
  • o Neutrophilic Dermatosis,
  • o Schnitzler syndrome,
  • o Vasculitis (Kawasaki, Behçet, Takayasu),
  • o Inflammation of unknown origin,
  • o Chronic osteitis.
  • For mSAID patients:
  • Patients with active disease (presence of a flare) according to the specific
  • criteria for each disease
  • Patients with monogenic hereditary SAID : FMF/TRAPS/HIDS/CAPS
  • For parents of guSAID patients
  • First-degree biological relationship (no adoption) with the index patient
  • Mother and Father over 18 years old
  • For negative control
  • Subject free of inflammatory disorders and negative CRP at enrollment
  • Subject without personal or familial history of SAID

排除标准

  • - Pregnant women
  • - Protected major subjects (under guardianship or curatorship) or under
  • judicial protection
  • - Refusal to sign the consent
  • - Major subject unable to express his consent
  • - Subjects not affiliated to a social security

研究者

发起方
INSERM - Clinical Research Department (PRC)

相似试验

Immunome project consortium for autoinflammatory... | 临床试验